Patients taking an antipsychotic drug from Otsuka America will be able to monitor their progress with smartphones provided by the drugmaker. That's thanks to a ruling by the HHS' Office of Inspector General that distributing the phones to patients does not constitute a violation of anti-kickback laws.
Ruling clears way for smartphone patient monitoring
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.